Search results
-
Kola Real: La expansión internacional
Ferré, Miguel; Natividad, GabrielCase PAD-DG-C-406EntrepreneurshipDescribe el caso de la internacionalización de una empresa peruana en varios países de la región, partiendo de unos modestos inicios en Ayacucho (1988). Se puede discutir la similitud o diferencias en la forma de nacer según el contexto de cada país.Starting at €8.20
-
The Pelayo Family Plays Roulette: The Prequel
Pfeifer, Phillip E.; Bodily, Samuel E.; Baucells, ManelCase DARDEN-QA-0847-EDecision AnalysisThe case presents data from 70,340 spins of four roulette wheels: three of which are real ("imperfect") and one of which is simulated ("perfect"). The challenge posed is to identify which of the four is the simulated wheel. After weeks spent recording spin results at their local casino, the members of the Pelayo family think they have identified three imperfect wheels. Before they start betting, they want to be certain that the three wheels they ...Starting at €8.20
-
A GLUM Primer: The Risk-Adjusted Expected Value
Pfeifer, Phillip E.; Bodily, Samuel E.; Baucells, ManelTechnical Note DARDEN-QA-0849-EDecision AnalysisThe purpose of this note is to improve on the expected value criterion by incorporating the willingness and capability to take risk of a rational decision maker. First, this note will review the concept of expected net present value (ENPV) and demonstrate its limitations. Next, we introduce the notion of play capital, or the most one is willing to put at risk in view of one’s life circumstances, goals, and resources. Then, we introduce the genera...Starting at €8.20
-
Vitaliy’s Purchase Decision
Baucells, Manel; Dydyshka, VitaliyExercise DARDEN-QA-0861-EDecision AnalysisThis short case presents the trade-offs that Vitaliy faces before purchasing a car. The case contains a consequence table showing five different cars and how they fare on six attributes, including price, user ratings, torque, fuel consumption, and engine power. The case is ideal to introduce the multiattribute methodology.Starting at €8.20
-
To LED or Not to LED?
Baucells, Manel; Yemen, GerryCase DARDEN-QA-0862-EDecision AnalysisA director of marketing at a major big-box retailer in the United States finds herself overhearing a customer and a lighting specialist discuss the replacement of incandescent and halogen lightbulbs with LEDs in his house. The case provides sufficient data to perform the economic analysis of which lightbulb is more cost effective in terms of net present value. The results are at odds with the student’s intuitions. This case uses a durable consume...Starting at €8.20
-
The Elevator Saga
Baucells, Manel; Yemen, GerryCase DARDEN-QA-0866-EDecision AnalysisThis case describes a common situation in old buildings, namely the decision as to whether intall an elevator. In this armchair case, we have an apartment building in Budapest with 3 towers, each containing 24 homeowners, with a possible interest in adding an elevator to each tower of the walk-up building. The case begins by discussing serveral ways to fairly distribute the cost if the elevators are approved. One way is an equal split. The second...Starting at €8.20
-
U.S. Universities and Technology Transfer
Hamermesh, Richard G.; Lerner, Josh; Andrews, PhillipCase HBS-812016-EEntrepreneurshipTechnology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the growth of technology transfer offices, and compares how three different universities (MIT, Stanford, and Harvard) approach technology transfer. Provides an overview of the technology tra...Starting at €8.20
-
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Hamermesh, Richard G.; Kucherlapati, Raju; Gordon, RachelCase HBS-810066-EEntrepreneurshipIn May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix...Starting at €8.20
-
Syndexa and Technology Transfer at Harvard University
Hamermesh, Richard G.; Kiron, DavidCase HBS-808073-EGokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the head of Harvard's Office of Technology Development (OTD) is eager to improve Harvard's record in commercializing science. Describes the negotiations between Hotamisligil, OTD, the ne...Starting at €8.20
-
Leadership and the Psychology of Turnarounds (Spanish version)
Kanter, Rosabeth MossArticle HBS-R0306CLeadership and People ManagementTurnaround champions--those leaders who manage to bring distressed organizations back from the brink of failure--are often acclaimed for their canny financial and strategic decision making. But having studied their work closely, Harvard Business School's Rosabeth Moss Kanter emphasizes another aspect of their achievement. These leaders reverse the cycle of corporate decline through deliberate interventions that increase the level of communication...Starting at €8.20